Riskpilot← Back to searchSign inGet full accessPro Treatment i Halmstad AB
ABActiveOrg 5567693303Norra Vägen 13Day spa, sauna and steam bath activities · NACE 9623Est. 20082 employees
Revenue 2025
SEK 1,7M
-7% vs 2024
EBITDA margin
1.4%
-57% vs 2024
Equity ratio
72.4%
Financial strength
Net profit 2025
SEK 24K
-47% vs 2024
| Revenue | SEK 1,7M | -7% |
| EBITDA | SEK 23K | -57% |
| Net profit | SEK 24K | -47% |
| Total assets | SEK 427K | -8% |
| Equity | SEK 309K | +9% |
| Employees | 2 | — |
Legal name
Pro Treatment i Halmstad AB
Org number
5567693303
Legal form
Aktiebolag
NACE code
9623 · Day spa, sauna and steam bath activities
Founded
10 november 2008
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva förebyggande och rehabiliterande hälsovård, massage, hälsoprofilsbedömningar, föreläsningar, kurser, träningsrådgivning och kostrådgivning samt försäljning av hälsoprodukter och bijouterier och därmed förenlig erksamhet.
Address
Norra Vägen 13
Phone
+46736227940
Email
solbackens@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 763 | 1 655 | 1 620 | 1 831 | 1 696 |
| Staff expenses | — | −1 136 | −1 208 | −1 288 | −1 182 |
| EBITDA | 223 | −65 | −115 | 54 | 23 |
| Depreciation & amort. | −23 | −23 | −23 | −11 | — |
| EBIT | 200 | −87 | −137 | 43 | 23 |
| Net financials | — | −0 | −12 | 3 | 1 |
| Profit before tax | 152 | −12 | −149 | 45 | 24 |
| Tax | −33 | — | — | — | — |
| Net profit | 119 | −12 | −149 | 45 | 24 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 681 | 559 | 392 | 464 | 427 |
| Equity | 400 | 388 | 239 | 284 | 309 |
| Long-term debt | 0 | — | 11 | 6 | 6 |
| Short-term debt | 206 | 171 | 142 | 174 | 112 |
| Total debt | 206 | 171 | 153 | 179 | 118 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
72.4%
This company
38.2%
Market median
+90% vs market
20212025
Return on equity
7.9%
This company
18.4%
Market median
-57% vs market
20212025
Net profit margin
1.4%
This company
8.1%
Market median
-83% vs market
20212025
Asset turnover
3.98×
This company
1.12×
Market median
+255% vs market
20212025
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pro Treatment i Halmstad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Magnus Hellström | Board of Directors | 0 companies |
| Wenche Elisabeth Hellström | Deputy Board Member | 0 companies |